Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,209 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (15.4bn) 0 No activity — 50%+
Healthcare Services Large (14.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (14.0bn) 0 No activity — 0–15%
Healthcare Services Large (13.8bn) -1–5 -$100M+ -15–50% 0–15%
DE Sartorius AG (SRT)
Healthcare Services Large (13.7bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (13.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (13.5bn) 0 No activity — 50%+
Healthcare Services Large (13.5bn) 0 No activity — 15–50%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (13.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (13.3bn) 0 No activity — 0–15%
Healthcare Services Large (13.3bn) 0 No activity — 15–50%
FI Orion Oyj (ORNBV)
Pharmaceuticals & Medical Research Large (13.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.9bn) 0 No activity — 50%+
US Penumbra Inc (PEN)
Healthcare Services Large (12.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.7bn) 0 No activity — 15–50%
IE ICON PLC (ICLR)
Pharmaceuticals & Medical Research Large (12.7bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.5bn) 0 No activity — 0–15%
Healthcare Services Large (12.5bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.4bn) 0 No activity — 50%+
Healthcare Services Large (12.4bn) -1–5 -$10M–$100M -0–15% 0–15%
FR Abivax SA (ABVX)
Pharmaceuticals & Medical Research Large (12.3bn) 0 No activity — 0–15%
US Revvity Inc (RVTY)
Healthcare Services Large (12.3bn) 0 No activity — 0–15%
Healthcare Services Large (12.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (12.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (11.7bn) 0 No activity — 0–15%
Healthcare Services Large (11.7bn) 0 No activity — 0–15%
Healthcare Services Large (11.6bn) 0 No activity — 15–50%
US Insulet Corp (PODD)
Healthcare Services Large (11.6bn) 1–5 $100K–$1M 0–15% 0–15%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 No activity — 0–15%
Healthcare Services Large (11.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US DaVita Inc (DVA)
Healthcare Services Large (11.3bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (11.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 1–5 $100K–$1M 0–15% 0–15%
US Glaukos Corp (GKOS)
Healthcare Services Large (11.0bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No activity — 15–50%
Healthcare Services Large (10.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.4bn) 1–5 $100M+ 0–15% 50%+
Pharmaceuticals & Medical Research Large (10.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.2bn) 0 No activity — 0–15%
Healthcare Services Large (10.2bn) 0 No activity — 0–15%
AU Cochlear Ltd (COH)
Healthcare Services Large (10.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (10.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 15–50%
US Nuvalent Inc (NUVL)
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (9.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.6bn) 0 No activity — 15–50%
DK Demant A/S (DEMANT)
Healthcare Services Mid (9.5bn) 1–5 $100K–$1M 0–15% 50%+
Healthcare Services Mid (9.5bn) 0 No activity — 15–50%
US Masimo Corp (MASI)
Healthcare Services Mid (9.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (9.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.1bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.1bn) 0 No activity — 0–15%
Healthcare Services Mid (8.9bn) 0 No activity — 0–15%
Healthcare Services Mid (8.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.9bn) 1–5 $1M–$10M 0–15% 0–15%
US ImmunoGen Inc (IMGN)
Pharmaceuticals & Medical Research Mid (8.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.6bn) -6–10 -$10M–$100M -0–15% 50%+
US Mylan NV (MYL)
Pharmaceuticals & Medical Research Mid (8.6bn) 0 No activity — 0–15%
US Bruker Corp (BRKR)
Healthcare Services Mid (8.6bn) 0 No activity — 15–50%
US Repligen Corp (RGEN)
Healthcare Services Mid (8.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (8.4bn) 0 No activity — 0–15%
IE Alkermes Plc (ALKS)
Pharmaceuticals & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (8.2bn) 0 No activity — 50%+
US Liquidia Corp (LQDA)
Pharmaceuticals & Medical Research Mid (8.0bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) 0 No activity — 0–15%
US Vaxcyte Inc (PCVX)
Pharmaceuticals & Medical Research Mid (7.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (7.6bn) 0 No activity — 0–15%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals & Medical Research Mid (7.4bn) 0 No activity — 50%+
Healthcare Services Mid (7.4bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (7.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.3bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (7.2bn) -1–5 -$100M+ -0–15% 0–15%
US Chemed Corp (CHE)
Healthcare Services Mid (7.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (7.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (7.1bn) -1–5 -$1M–$10M -0–15% 15–50%
ES Grifols SA (GRF)
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (7.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 50%+
US Merus NV (MRUS)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 50%+
NL Qiagen NV (QIA)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 0–15%
US Medicines Co (MDCO)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — —
Pharmaceuticals & Medical Research Mid (6.8bn) 1–5 $10M–$100M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — 0–15%
SE Getinge AB (GETI-B)
Healthcare Services Mid (6.7bn) 1–5 $100K–$1M 0–15% 15–50%
US Arcellx Inc (ACLX)
Pharmaceuticals & Medical Research Mid (6.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.7bn) 0 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.4bn) 0 No activity — 15–50%
US Erasca Inc (ERAS)
Pharmaceuticals & Medical Research Mid (6.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.2bn) 0 No activity — 0–15%